These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21350858)

  • 61. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
    Leblond V; Davi F; Charlotte F; Dorent R; Bitker MO; Sutton L; Gandjbakhch I; Binet JL; Raphael M
    J Clin Oncol; 1998 Jun; 16(6):2052-9. PubMed ID: 9626203
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
    Nalesnik MA; Jaffe R; Starzl TE; Demetris AJ; Porter K; Burnham JA; Makowka L; Ho M; Locker J
    Am J Pathol; 1988 Oct; 133(1):173-92. PubMed ID: 2845789
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of Clinical Features and Outcome of Pediatric Posttransplant Lymphoproliferative Disorder in Recipients of Small Bowel Allograft Versus Isolated Liver Transplantation.
    Chiou FK; Beath SV; Morland B; Hartley J; van Mourik I; Abdel-Hady M; Kelly DA; Sharif K; Gupte GL
    Transplantation; 2020 Jul; 104(7):1429-1436. PubMed ID: 31651718
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
    J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
    [TBL] [Abstract][Full Text] [Related]  

  • 65. EBV-PTLD in a patient after haploidentical stem-cell transplantation with post-transplant cyclophosphamide.
    Terao T; Tsushima T; Fukumoto A; Kuzume A; Miura D; Narita K; Takeuchi M; Matsue K
    Int J Hematol; 2021 Jul; 114(1):136-140. PubMed ID: 33675520
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Posttransplantation lymphoproliferative disorders.
    Andreone P; Gramenzi A; Lorenzini S; Biselli M; Cursaro C; Pileri S; Bernardi M
    Arch Intern Med; 2003 Sep; 163(17):1997-2004. PubMed ID: 14504111
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
    Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
    Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
    Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
    Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical aspects of Epstein-Barr-virus-associated lymphoproliferative disease].
    Kvell K; Balogh P; Németh P
    Orv Hetil; 2002 Apr; 143(14):713-9. PubMed ID: 11975391
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review.
    Sprangers B; Riella LV; Dierickx D
    Am J Kidney Dis; 2021 Aug; 78(2):272-281. PubMed ID: 33774079
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.
    Harris NL; Ferry JA; Swerdlow SH
    Semin Diagn Pathol; 1997 Feb; 14(1):8-14. PubMed ID: 9044505
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.
    Dotti G; Fiocchi R; Motta T; Gamba A; Gotti E; Gridelli B; Borleri G; Manzoni C; Viero P; Remuzzi G; Barbui T; Rambaldi A
    Transplantation; 2000 Mar; 69(5):827-33. PubMed ID: 10755535
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes.
    Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
    Transplantation; 1995 Feb; 59(4):637-40. PubMed ID: 7533350
    [No Abstract]   [Full Text] [Related]  

  • 74. Reexamining post-transplant lymphoproliferative disorders: Newly recognized and enigmatic types.
    Aguilera N; Gru AA
    Semin Diagn Pathol; 2018 Jul; 35(4):236-246. PubMed ID: 29615296
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation.
    Kalra A; Roessner C; Jupp J; Williamson T; Tellier R; Chaudhry A; Khan F; Taparia M; Jimenez-Zepeda VH; Stewart DA; Daly A; Storek J
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29114932
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Epstein-Barr virus-associated lymphoproliferations and lymphomas].
    Anagnostopoulos I; Jöhrens K
    Pathologe; 2013 May; 34(3):262-71. PubMed ID: 23512137
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.
    Tanner JE; Alfieri C
    Transpl Infect Dis; 2001 Jun; 3(2):60-9. PubMed ID: 11395971
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-CD20 monoclonal antibody treatment of Epstein-Barr virus-induced intrahepatic lymphoproliferative disorder following liver transplantation.
    Yedibela S; Reck T; Niedobitek G; Gramatzki M; Repp R; Hohenberger W; Ott R
    Transpl Int; 2003 Mar; 16(3):197-201. PubMed ID: 12664216
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?
    Nelson BP; Nalesnik MA; Bahler DW; Locker J; Fung JJ; Swerdlow SH
    Am J Surg Pathol; 2000 Mar; 24(3):375-85. PubMed ID: 10716151
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach.
    Nalesnik MA
    Transpl Infect Dis; 2001 Jun; 3(2):88-96. PubMed ID: 11395974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.